首页 › 基金 › JTC Employer Solutions Trustee Ltd › GSK

JTC Employer Solutions Trustee Ltd 对 GSK 的持仓历史

GSK PLC · 医疗保健

JTC Employer Solutions Trustee Ltd 在 Q3 2026 的 13F 申报中披露持有 GSK(GSK PLC)8,077,477 股,市值约 US$389.2M,约占其申报组合的 33.51%,在其申报持仓中市值排名第 1 位。 JTC Employer Solutions Trustee Ltd 最近 13 个申报季度中有 13 个季度披露了 GSK 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)8.08M 股
申报持仓市值$389.17M
组合权重33.51%
首次申报Q3 2023
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

JTC Employer Solutions Trustee Ltd 对 GSK 的持仓演变

JTC Employer Solutions Trustee Ltd 于 Q3 2023 首次披露 GSK 持仓:12,444,460 股(约 US$451.1M)。 该持仓在 Q1 2024 达到峰值 21,141,012 股,市值约 US$909.1M。 在 13 次申报中,JTC Employer Solutions Trustee Ltd 1 次增持、11 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 8,077,477 股、市值约 US$389.2M,环比减持 -515,510 股。。 持仓曾出现大幅变动:Q1 2024 增持约 71% (随后一个季度股价下跌 10%)、Q1 2026 减持约 37% (随后一个季度股价下跌 5%)。

逐季持仓明细

季度股数金额变化
Q3 2023 12.44M $451.11M 新进
Q4 2023 12.34M $457.76M 减持
Q1 2024 21.14M $909.06M 增持
Q2 2024 20.88M $803.79M 减持
Q3 2024 20.48M $837.36M 减持
Q4 2024 20.28M $682.27M 减持
Q1 2025 15.26M $591.57M 减持
Q2 2025 15.00M $575.67M 减持
Q3 2025 14.60M $629.94M 减持
Q4 2025 14.43M $707.69M 减持
Q1 2026 9.04M $498.91M 减持
Q2 2026 8.59M $450.31M 减持
Q3 2026 8.08M $389.17M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 GSK 与 13F 数据

GSK(GSK PLC)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 GSK,申报仓位最大的包括:Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GSK 的基金

查看 GSK 的全部基金持有人 →

常见问题

How long has JTC Employer Solutions Trustee Ltd held GSK?

JTC Employer Solutions Trustee Ltd has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is JTC Employer Solutions Trustee Ltd's current position in GSK?

As of Q3 2026, JTC Employer Solutions Trustee Ltd holds 8.08M shares of GSK (GSK PLC), valued at $389.17M, representing 33.51% of its reported portfolio and ranking #1.

Has JTC Employer Solutions Trustee Ltd been buying or selling GSK?

In the latest 13F filing (Q3 2026), JTC Employer Solutions Trustee Ltd reduced its position in GSK. The position peaked in Q1 2024 at 21.14M shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.